Immune cells in glioblastoma use fructose to evade immune response, pointing to a new treatment target. Northwestern Medicine ...

To test whether AT2‑derived lipids are required for metastasis, the researchers selectively deleted Fasn in AT2 cells.

India, March 19 -- Tech giant Microsoft has unveiled a new artificial intelligence model called GigaTIME, which could ...

Cancer dysregulates the immune response to evade cell death and progress throughout the body. As tumors become established, ...

Iron metabolism represents a key area of cancer research, as iron is crucial for cellular proliferation and many metabolic processes. Tumors often exhibit ...

As a potential biomarker of treatment response, ctDNA and utDNA analyses were performed before systemic therapy, at restaging, and for responders at the beginning of adjuvant nivolumab. ctDNA was ...

Engineers at the University of Pennsylvania have built a lipid nanoparticle that chemically fuses an IDO-pathway inhibitor with the very lipids that carry IL-12 mRNA into tumors, creating a single ...

A team of scientists at Henry Ford Health + Michigan State University Health Sciences have uncovered a mechanism that allows ...

Per-protocol survival improved versus earlier cutoffs, with 35% alive beyond 30 months and 13% beyond 50 months after two ...

A vanadium MXene nanoparticle uses gene editing to strip tumors of heat resistance, then kills them with laser-triggered free ...

Penn Engineers have developed a new type of lipid nanoparticle (LNP) that could one day serve as a universal immunotherapy for cancers that form solid tumors. The particle delivers both mRNA that ...

MDNA113 is a novel IL-13Rα2 tumor-targeted and “masked” anti-PD-1-IL-2 Superkine (anti-PD1-IL-2SK), engineered to precisely deliver clinically ...